MRAI.OQXMarpai, INC

Form 4: Marpai CFO Steve Johnson Reports Stock Transactions and RSU Vesting Conditions

Sentiment:

SEC Form 4 Filing


Marpai's Chief Financial Officer, Steve Johnson, reported the acquisition of 100,000 shares of Class A Common Stock as a grant and the purchase of 5,000 shares, along with details on vesting conditions for restricted stock units.

Summary

  • Steve Johnson, the Chief Financial Officer of Marpai, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
  • On May 24, 2024, Johnson acquired 100,000 shares of Class A Common Stock as a grant at a price of $0.
  • On December 5, 2024, Johnson purchased 5,000 shares of Class A Common Stock at a price of $1.13 per share.
  • Following these transactions, Johnson's total direct holdings increased to 473,061 shares of Class A Common Stock.
  • The report also details that Johnson holds restricted stock units (RSUs) that will vest when the company achieves a year-end unadjusted EBITDA of $5 million or more, contingent on his continued employment.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of stock transactions and vesting conditions. While the stock purchases by the CFO are a positive sign, the document does not provide enough information to make a strong positive or negative assessment.

Positives

  • The acquisition of shares by the CFO could be seen as a positive sign of confidence in the company's future performance.
  • The vesting of RSUs is tied to a specific financial performance target (EBITDA of $5 million), which could incentivize management to achieve this goal.

Risks

  • The vesting of RSUs is contingent on the company achieving a specific EBITDA target, which may not be met.
  • The document does not provide any information on the company's current financial performance or its likelihood of achieving the EBITDA target.

Future Outlook

The vesting of RSUs is dependent on the company achieving a specific financial target, suggesting a focus on improving financial performance.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. The vesting conditions tied to EBITDA are a common incentive mechanism.

Comparison to Industry Standards

  • Stock grants and purchases by executives are standard practice in publicly traded companies, and the reporting of these transactions via SEC Form 4 is a regulatory requirement.
  • The use of EBITDA targets for vesting of restricted stock units is a common practice to align management incentives with company performance, similar to practices at companies like Teladoc Health and Livongo before their merger.

Stakeholder Impact

  • The stock transactions and vesting conditions may be of interest to shareholders as they reflect management's alignment with company performance.
  • The achievement of the EBITDA target could positively impact shareholder value.

Key Dates

DateDescription
05/24/2024Date of grant of 100,000 shares of Class A Common Stock to Steve Johnson.
12/05/2024Date of purchase of 5,000 shares of Class A Common Stock by Steve Johnson.
12/09/2024Date of signature of the Form 4 by Steve Johnson.

Keywords

Marpai, Steve Johnson, Form 4, Beneficial Ownership, Class A Common Stock, Restricted Stock Units, EBITDA, Stock Transactions, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.